| Literature DB >> 28326001 |
Grace Akinyi Odongo1, Nina Schlotz1, Corinna Herz1, Franziska S Hanschen2, Susanne Baldermann2, Susanne Neugart2, Bernhard Trierweiler3, Lara Frommherz3, Charles M A P Franz4, Benard Ngwene2, Abraham Wahid Luvonga5, Monika Schreiner2, Sascha Rohn5, Evelyn Lamy1.
Abstract
Background: Ethiopian kale (Brassica carinata) is a horticulturally important crop used as leafy vegetable in large parts of East and Southern Africa. The leaves are reported to contain high concentrations of health-promoting secondary plant metabolites. However, scientific knowledge on their health benefits is scarce. Objective: This study aimed to determine the cancer preventive potential of B. carinata using a human liver in vitro model focusing on processing effects on the pattern of secondary plant metabolites and bioactivity. Design: B. carinata was cultivated under controlled conditions and differentially processed (raw, fermented, or cooked) after harvesting. Human liver cancer cells (HepG2) were treated with ethanolic extracts of raw or processed B. carinata leaves and analyzed for their anti-genotoxic, anti-oxidant, and cytostatic potential. Chemical analyses were carried out on glucosinolates including breakdown products, phenolic compounds, carotenoids, and chlorophyll content. <br> Results: Pre-treatment with B. carinata extracts concentration dependently reduced aflatoxin-induced DNA damage in the Comet assay, reduced the production of reactive oxygen species as determined by electron paramagnetic resonance spectroscopy, and induced Nrf2-mediated gene expression. Increasing extract concentrations also promoted cytostasis. Processing had a significant effect on the content of secondary plant metabolites. However, different processing methodologies did not dramatically decrease bioactivity, but enhanced the protective effect in some of the endpoints studied. <br> Conclusion: Our findings highlight the cancer preventive potential of B. carinata as indicated by the protection of human liver cells against aflatoxin in vitro. In general, consumption of B. carinata should be encouraged as part of chemopreventive measures to combat prevalence of aflatoxin-induced diseases.Entities:
Keywords: Aflatoxin B1; African leafy vegetables; Brassicaceae; anti-genotoxicity; cancer chemoprevention; glucosinolates; polyphenols; secondary plant metabolites
Year: 2017 PMID: 28326001 PMCID: PMC5328379 DOI: 10.1080/16546628.2017.1271527
Source DB: PubMed Journal: Food Nutr Res ISSN: 1654-661X Impact factor: 3.894
Figure 1. Inflorescences (A) and leaves (B) of B. carinata.
Figure 2. Anti-genotoxic potential of ethanolic extracts of raw and processed B. carinata. DNA damage in AFB1-treated cells is shown as percent of control. Data are means ± SEM of three independent experiments. Asterisks indicate statistically significant differences between the respective treatment and the positive control (= without B. carinata extract). SC = solvent control (0.1% DMSO).
Figure 3. Anti-oxidative potential of ethanolic extracts of raw and processed B. carinata. A and B) ROS production as determined by the EPR method in response to 200 µM menadione in cells pre-treated with B. carinata extracts. C) and D) Induction of ARE/Nrf-2-mediated gene expression in cells treated with B. carinata extracts. Data are means ± SEM of three independent experiments expressed as percent of control. Asterisks indicate statistically significant differences between the respective treatment and the positive control (= without B. carinata extract; A, B) or the SC (C, D). SC = solvent control (0.7% EtOH).
Figure 4. Cytotoxic (A,B) and cytostatic (C, D) potential of ethanolic extracts of raw and processed B. carinata. Data are means ± SEM of three independent experiments. Asterisks indicate statistically significant differences between the respective treatment and SC. SC = solvent control (0.7% EtOH).
Figure 5. Total content of secondary plant metabolites in ethanolic extracts of raw, fermented, and cooked B. carinata. Results are presented in µg/mL on a logarithmic scale. The first raw and fermented extracts are from location A, while the second raw and cooked extracts are from location B.